Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis

被引:4
作者
Pugliese, Daniela [1 ]
Armuzzi, Alessandro [1 ,2 ]
机构
[1] Fdn Policlin Univ A Gemelli IRCCS, IBD Unit Presidio Columbus, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
INFLAMMATORY-BOWEL-DISEASE; THERAPY;
D O I
10.1177/2050640619900575
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:11 / 12
页数:2
相关论文
共 7 条
[1]   One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study [J].
Amiot, A. ;
Serrero, M. ;
Peyrin-Biroulet, L. ;
Filippi, J. ;
Pariente, B. ;
Roblin, X. ;
Buisson, A. ;
Stefanescu, C. ;
Trang-Poisson, C. ;
Altwegg, R. ;
Marteau, P. ;
Vaysse, T. ;
Bourrier, A. ;
Nancey, S. ;
Laharie, D. ;
Allez, M. ;
Savoye, G. ;
Moreau, J. ;
Vuitton, L. ;
Viennot, S. ;
Aubourg, A. ;
Pelletier, A. -L. ;
Bouguen, G. ;
Abitbol, V. ;
Gagniere, C. ;
Bouhnik, Y. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (03) :310-321
[2]   Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission [J].
Armuzzi, Alessandro ;
Pugliese, Daniela ;
Danese, Silvio ;
Rizzo, Gianluca ;
Felice, Carla ;
Marzo, Manuela ;
Andrisani, Gialuca ;
Fiorino, Gionata ;
Sociale, Orsola ;
Papa, Alfredo ;
De Vitis, Italo ;
Rapaccini, Gian Lodovico ;
Guidi, Luisa .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (05) :1065-1072
[3]   Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review [J].
Fumery, Mathurin ;
Singh, Siddharth ;
Dulai, Parambir S. ;
Gower-Rousseau, Corinne ;
Peyrin-Biroulet, Laurent ;
Sandborn, William J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) :343-+
[4]   Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population [J].
Ha, Christina ;
Ullman, Thomas A. ;
Siegel, Corey A. ;
Kornbluth, Asher .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (09) :1002-1007
[5]   Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis [J].
Ochsenkuehn, Thomas ;
Tillack, Cornelia ;
Szokodi, Daniel ;
Janelidze, Shorena ;
Schnitzler, Fabian .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (01) :91-98
[6]   Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].
Sands, B. E. ;
Sandborn, W. J. ;
Panaccione, R. ;
O'Brien, C. D. ;
Zhang, H. ;
Johanns, J. ;
Adedokun, O. J. ;
Li, K. ;
Peyrin-Biroulet, L. ;
Van Assche, G. ;
Danese, S. ;
Targan, S. ;
Abreu, M. T. ;
Hisamatsu, T. ;
Szapary, P. ;
Marano, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13) :1201-1214
[7]   The Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis [J].
Sands, Bruce E. ;
Cheifetz, Adam S. ;
Nduaka, Chudy I. ;
Quirk, Daniel ;
Wang, Wenjin ;
Maller, Eric ;
Friedman, Gary S. ;
Su, Chinyu ;
Higginsd, Peter D. R. .
JOURNAL OF CROHNS & COLITIS, 2019, 13 (09) :1217-1226